Regulation of hepatic microRNA expression by hepatocyte nuclear factor 4 alpha

World Journal of Hepatology

Volumn 9, Issue 4, 2017, Pages 191-208

  Lu, Hong ^a   Lei, Xiaohong ^a   Liu, Jerry ^b   Klaassen, Curtis ^b  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Hepatocyte nuclear factor 4 alpha; Human; Knockout; Liver; Mice; MiR 101; miR 122; MiR 192; MiR 194; MiR 802

Indexed keywords

EID: 85013015686     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v9.i4.191     Document Type: Article

References (92)

1. Lu H, Gonzalez FJ, Klaassen C. Alterations in hepatic mRNA expression of phase II enzymes and xenobiotic transporters after targeted disruption of hepatocyte nuclear factor 4 alpha. Toxicol Sci 2010; 118: 380-390 [PMID: 20935164 DOI: 10.1093/toxsci/ kfq280]
2. Lu H. Crosstalk of HNF4α with extracellular and intracellular signaling pathways in the regulation of hepatic metabolism of drugs and lipids. Acta Pharm Sin B 2016; 6: 393-408 [PMID: 27709008 DOI: 10.1016/j.apsb.2016.07.003]
3. Battle MA, Konopka G, Parviz F, Gaggl AL, Yang C, Sladek FM, Duncan SA. Hepatocyte nuclear factor 4alpha orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver. Proc Natl Acad Sci USA 2006; 103: 8419-8424 [PMID: 16714383 DOI: 10.1073/pnas.0600246103]
4. Li J, Ning G, Duncan SA. Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha. Genes Dev 2000; 14: 464-474 [PMID: 10691738]
5. Kyrmizi I, Hatzis P, Katrakili N, Tronche F, Gonzalez FJ, Talianidis I. Plasticity and expanding complexity of the hepatic transcription factor network during liver development. Genes Dev 2006; 20: 2293-2305 [PMID: 16912278 DOI: 10.1101/gad.390906]
6. Hayhurst GP, Lee YH, Lambert G, Ward JM, Gonzalez FJ. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol 2001; 21: 1393-1403 [PMID: 11158324 DOI: 10.1128/ MCB.21.4.1393-1403.2001]
7. Gonzalez FJ. Regulation of hepatocyte nuclear factor 4 alphamediated transcription. Drug Metab Pharmacokinet 2008; 23: 2-7 [PMID: 18305369 DOI: 10.2133/dmpk.23.2]
8. Yin C, Lin Y, Zhang X, Chen YX, Zeng X, Yue HY, Hou JL, Deng X, Zhang JP, Han ZG, Xie WF. Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene. Hepatology 2008; 48: 1528-1539 [PMID: 18925631 DOI: 10.1002/hep.22510]
9. Ning BF, Ding J, Yin C, Zhong W, Wu K, Zeng X, Yang W, Chen YX, Zhang JP, Zhang X, Wang HY, Xie WF. Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma. Cancer Res 2010; 70: 7640-7651 [PMID: 20876809 DOI: 10.1158/0008-5472.CAN-10-0824]
10. Inoue Y, Yu AM, Yim SH, Ma X, Krausz KW, Inoue J, Xiang CC, Brownstein MJ, Eggertsen G, Björkhem I, Gonzalez FJ. Regulation of bile acid biosynthesis by hepatocyte nuclear factor 4alpha. J Lipid Res 2006; 47: 215-227 [PMID: 16264197 DOI: 10.1194/jlr. M500430-JLR200]
11. Inoue Y, Hayhurst GP, Inoue J, Mori M, Gonzalez FJ. Defective ureagenesis in mice carrying a liver-specific disruption of hepatocyte nuclear factor 4alpha (HNF4αlpha ). HNF4αlpha regulates ornithine transcarbamylase in vivo. J Biol Chem 2002; 277: 25257-25265 [PMID: 11994307 DOI: 10.1074/jbc.M203126200]
12. Inoue Y, Yu AM, Inoue J, Gonzalez FJ. Hepatocyte nuclear factor 4alpha is a central regulator of bile acid conjugation. J Biol Chem 2004; 279: 2480-2489 [PMID: 14583614 DOI: 10.1074/jbc.M3110 15200]
13. Hwang-Verslues WW, Sladek FM. HNF4α--role in drug metabolism and potential drug target? Curr Opin Pharmacol 2010; 10: 698-705 [PMID: 20833107 DOI: 10.1016/j.coph.2010.08.010]
14. Wiwi CA, Gupte M, Waxman DJ. Sexually dimorphic P450 gene expression in liver-specific hepatocyte nuclear factor 4alphadeficient mice. Mol Endocrinol 2004; 18: 1975-1987 [PMID: 15155787 DOI: 10.1210/me.2004-0129]
15. Wortham M, Czerwinski M, He L, Parkinson A, Wan YJ. Expression of constitutive androstane receptor, hepatic nuclear factor 4 alpha, and P450 oxidoreductase genes determines interindividual variability in basal expression and activity of a broad scope of xenobiotic metabolism genes in the human liver. Drug Metab Dispos 2007; 35: 1700-1710 [PMID: 17576804 DOI: 10.1124/dmd.107.016436]
16. Ryffel GU. Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: functional and pathological consequences. J Mol Endocrinol 2001; 27: 11-29 [PMID: 11463573 DOI: 10.1677/ jme.0.0270011]
17. Zhou Z, Kang X, Jiang Y, Song Z, Feng W, McClain CJ, Kang YJ. Preservation of hepatocyte nuclear factor-4alpha is associated with zinc protection against TNF-alpha hepatotoxicity in mice. Exp Biol Med (Maywood) 2007; 232: 622-628 [PMID: 17463158]
18. Lazarevich NL, Cheremnova OA, Varga EV, Ovchinnikov DA, Kudrjavtseva EI, Morozova OV, Fleishman DI, Engelhardt NV, Duncan SA. Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors. Hepatology 2004; 39: 1038-1047 [PMID: 15057908 DOI: 10.1002/ hep.20155]
19. Berasain C, Herrero JI, García-Trevijano ER, Avila MA, Esteban JI, Mato JM, Prieto J. Expression of Wilms' tumor suppressor in the liver with cirrhosis: relation to hepatocyte nuclear factor 4 and hepatocellular function. Hepatology 2003; 38: 148-157 [PMID: 12829997 DOI: 10.1053/jhep.2003.50269]
20. Kang X, Zhong W, Liu J, Song Z, McClain CJ, Kang YJ, Zhou Z. Zinc supplementation reverses alcohol-induced steatosis in mice through reactivating hepatocyte nuclear factor-4alpha and peroxisome proliferator-activated receptor-alpha. Hepatology 2009; 50: 1241-1250 [PMID: 19637192 DOI: 10.1002/hep.23090]
21. Zhang Q, Lei X, Lu H. Alterations of epigenetic signatures in hepatocyte nuclear factor 4a deficient mouse liver determined by improved ChIP-qPCR and (h)MeDIP-qPCR assays. PLoS One 2014; 9: e84925 [PMID: 24427299 DOI: 10.1371/journal.pone.0084925]
22. Tsang DP, Cheng AS. Epigenetic regulation of signaling pathways in cancer: role of the histone methyltransferase EZH2. J Gastroenterol Hepatol 2011; 26: 19-27 [PMID: 21175789 DOI: 10.1111/j.1440-1746.2010.06447.x]
23. Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL, Volkert TL, Schreiber J, Rolfe PA, Gifford DK, Fraenkel E, Bell GI, Young RA. Control of pancreas and liver gene expression by HNF transcription factors. Science 2004; 303: 1378-1381 [PMID: 14988562 DOI: 10.1126/science.1089769]
24. Odom DT, Dowell RD, Jacobsen ES, Gordon W, Danford TW, MacIsaac KD, Rolfe PA, Conboy CM, Gifford DK, Fraenkel E. Tissue-specific transcriptional regulation has diverged significantly between human and mouse. Nat Genet 2007; 39: 730-732 [PMID: 17529977 DOI: 10.1038/ng2047]
25. Schmidt D, Wilson MD, Ballester B, Schwalie PC, Brown GD, Marshall A, Kutter C, Watt S, Martinez-Jimenez CP, Mackay S, Talianidis I, Flicek P, Odom DT. Five-vertebrate ChIP-seq reveals the evolutionary dynamics of transcription factor binding. Science 2010; 328: 1036-1040 [PMID: 20378774 DOI: 10.1126/science.1186176]
26. Hoffman BG, Robertson G, Zavaglia B, Beach M, Cullum R, Lee S, Soukhatcheva G, Li L, Wederell ED, Thiessen N, Bilenky M, Cezard T, Tam A, Kamoh B, Birol I, Dai D, Zhao Y, Hirst M, Verchere CB, Helgason CD, Marra MA, Jones SJ, Hoodless PA. Locus co-occupancy, nucleosome positioning, and H3K4me1 regulate the functionality of FOXA2-, HNF4A-, and PDX1-bound loci in islets and liver. Genome Res 2010; 20: 1037-1051 [PMID: 20551221 DOI: 10.1101/gr.104356.109]
27. Otsuka M, Kishikawa T, Yoshikawa T, Ohno M, Takata A, Shibata C, Koike K. The role of microRNAs in hepatocarcinogenesis: current knowledge and future prospects. J Gastroenterol 2014; 49: 173-184 [PMID: 24258409 DOI: 10.1007/s00535-013-0909-8]
28. Ritchie ME, Silver J, Oshlack A, Holmes M, Diyagama D, Holloway A, Smyth GK. A comparison of background correction methods for two-colour microarrays. Bioinformatics 2007; 23: 2700-2707 [PMID: 17720982 DOI: 10.1093/bioinformatics/ btm412]
29. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95: 14863-14868 [PMID: 9843981 DOI: 10.1073/ pnas.95.25.14863]
30. Vermeulen M, Mulder KW, Denissov S, Pijnappel WW, van Schaik FM, Varier RA, Baltissen MP, Stunnenberg HG, Mann M, Timmers HT. Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4. Cell 2007; 131: 58-69 [PMID: 17884155 DOI: 10.1016/j.cell.2007.08.016]
31. Kimura H. Histone modifications for human epigenome analysis. J Hum Genet 2013; 58: 439-445 [PMID: 23739122 DOI: 10.1038/ jhg.2013.66]
32. Kolasinska-Zwierz P, Down T, Latorre I, Liu T, Liu XS, Ahringer J. Differential chromatin marking of introns and expressed exons by H3K36me3. Nat Genet 2009; 41: 376-381 [PMID: 19182803 DOI: 10.1038/ng.322]
33. Pauler FM, Sloane MA, Huang R, Regha K, Koerner MV, Tamir I, Sommer A, Aszodi A, Jenuwein T, Barlow DP. H3K27me3 forms BLOCs over silent genes and intergenic regions and specifies a histone banding pattern on a mouse autosomal chromosome. Genome Res 2009; 19: 221-233 [PMID: 19047520 DOI: 10.1101/ gr.080861.108].
34. Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP. Integrative genomics viewer. Nat Biotechnol 2011; 29: 24-26 [PMID: 21221095 DOI: 10.1038/nbt.1754]
35. Liu JJ, Lin XJ, Yang XJ, Zhou L, He S, Zhuang SM, Yang J. A novel AP-1/miR-101 regulatory feedback loop and its implication in the migration and invasion of hepatoma cells. Nucleic Acids Res 2014; 42: 12041-12051 [PMID: 25260594 DOI: 10.1093/nar/ gku872]
36. Krützfeldt J, Rösch N, Hausser J, Manoharan M, Zavolan M, Stoffel M. MicroRNA-194 is a target of transcription factor 1 (Tcf1, HNF1a) in adult liver and controls expression of frizzled-6. Hepatology 2012; 55: 98-107 [PMID: 21887698 DOI: 10.1002/ hep.24658]
37. Hino K, Tsuchiya K, Fukao T, Kiga K, Okamoto R, Kanai T, Watanabe M. Inducible expression of microRNA-194 is regulated by HNF-1alpha during intestinal epithelial cell differentiation. RNA 2008; 14: 1433-1442 [PMID: 18492795 DOI: 10.1261/rna.810208].
38. Sandelin A, Wasserman WW. Prediction of nuclear hormone receptor response elements. Mol Endocrinol 2005; 19: 595-606 [PMID: 15563547 DOI: 10.1210/me.2004-0101]
39. Bolotin E, Liao H, Ta TC, Yang C, Hwang-Verslues W, Evans JR, Jiang T, Sladek FM. Integrated approach for the identification of human hepatocyte nuclear factor 4alpha target genes using protein binding microarrays. Hepatology 2010; 51: 642-653 [PMID: 20054869 DOI: 10.1002/hep.23357]
40. Gaspar-Maia A, Alajem A, Polesso F, Sridharan R, Mason MJ, Heidersbach A, Ramalho-Santos J, McManus MT, Plath K, Meshorer E, Ramalho-Santos M. Chd1 regulates open chromatin and pluripotency of embryonic stem cells. Nature 2009; 460: 863-868 [PMID: 19587682 DOI: 10.1038/nature08212]
41. Cheung L, Gustavsson C, Norstedt G, Tollet-Egnell P. Sexdifferent and growth hormone-regulated expression of microRNA in rat liver. BMC Mol Biol 2009; 10: 13 [PMID: 19236699 DOI: 10.1186/1471-2199-10-13]
42. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005; 309: 1577-1581 [PMID: 16141076 DOI: 10.1126/science.1113329]
43. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, Mendell JR, Mendell JT. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009; 137: 1005-1017 [PMID: 19524505 DOI: 10.1016/ j.cell.2009.04.021]
44. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, Jackson AL, Linsley PS, Chen C, Lowe SW, Cleary MA, Hannon GJ. A microRNA component of the p53 tumour suppressor network. Nature 2007; 447: 1130-1134 [PMID: 17554337 DOI: 10.1038/nature05939]
45. Xu T, Zhu Y, Xiong Y, Ge YY, Yun JP, Zhuang SM. MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology 2009; 50: 113-121 [PMID: 19441017 DOI: 10.1002/hep.22919]
46. Lu Y, Thomson JM, Wong HY, Hammond SM, Hogan BL. Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Dev Biol 2007; 310: 442-453 [PMID: 17765889 DOI: 10.1016/j.ydbio.2007.08.007]
47. Cicchini C, de Nonno V, Battistelli C, Cozzolino AM, De Santis Puzzonia M, Ciafrè SA, Brocker C, Gonzalez FJ, Amicone L, Tripodi M. Epigenetic control of EMT/MET dynamics: HNF4α impacts DNMT3s through miRs-29. Biochim Biophys Acta 2015; 1849: 919-929 [PMID: 26003733 DOI: 10.1016/j.bbagrm. 2015.05.005]
48. Yin C, Wang PQ, Xu WP, Yang Y, Zhang Q, Ning BF, Zhang PP, Zhou WP, Xie WF, Chen WS, Zhang X. Hepatocyte nuclear factor-4a reverses malignancy of hepatocellular carcinoma through regulating miR-134 in the DLK1-DIO3 region. Hepatology 2013; 58: 1964-1976 [PMID: 23775631 DOI: 10.1002/hep.26573]
49. Hatziapostolou M, Polytarchou C, Aggelidou E, Drakaki A, Poultsides GA, Jaeger SA, Ogata H, Karin M, Struhl K, Hadzopoulou-Cladaras M, Iliopoulos D. An HNF4α-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell 2011; 147: 1233-1247 [PMID: 22153071 DOI: 10.1016/j.cell.2011. 10.043]
50. Hong YH, Varanasi US, Yang W, Leff T. AMP-activated protein kinase regulates HNF4αlpha transcriptional activity by inhibiting dimer formation and decreasing protein stability. J Biol Chem 2003; 278: 27495-27501 [PMID: 12740371 DOI: 10.1074/jbc. M304112200]
51. Hwang-Verslues WW, Sladek FM. Nuclear receptor hepatocyte nuclear factor 4alpha1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter. Mol Endocrinol 2008; 22: 78-90 [PMID: 17885207 DOI: 10.1210/me.2007-0298]
52. Blume SW, Snyder RC, Ray R, Thomas S, Koller CA, Miller DM. Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J Clin Invest 1991; 88: 1613-1621 [PMID: 1834700 DOI: 10.1172/JCI115474]
53. Jover R, Bort R, Gómez-Lechón MJ, Castell JV. Re-expression of C/EBP alpha induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells. FEBS Lett 1998; 431: 227-230 [PMID: 9708908 DOI: 10.1016/S0014-5793(98)00746-7]
54. Meng Z, Fu X, Chen X, Zeng S, Tian Y, Jove R, Xu R, Huang W. miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice. Hepatology 2010; 52: 2148-2157 [PMID: 20979124 DOI: 10.1002/hep.23915]
55. Walesky C, Edwards G, Borude P, Gunewardena S, O'Neil M, Yoo B, Apte U. Hepatocyte nuclear factor 4 alpha deletion promotes diethylnitrosamine-induced hepatocellular carcinoma in rodents. Hepatology 2013; 57: 2480-2490 [PMID: 23315968 DOI: 10.1002/hep.26251]
56. Bonzo JA, Ferry CH, Matsubara T, Kim JH, Gonzalez FJ. Suppression of hepatocyte proliferation by hepatocyte nuclear factor 4a in adult mice. J Biol Chem 2012; 287: 7345-7356 [PMID: 22241473 DOI: 10.1074/jbc.M111.334599]
57. Walesky C, Gunewardena S, Terwilliger EF, Edwards G, Borude P, Apte U. Hepatocyte-specific deletion of hepatocyte nuclear factor-4a in adult mice results in increased hepatocyte proliferation. Am J Physiol Gastrointest Liver Physiol 2013; 304: G26-G37 [PMID: 23104559 DOI: 10.1152/ajpgi.00064.2012]
58. Cattin AL, Le Beyec J, Barreau F, Saint-Just S, Houllier A, Gonzalez FJ, Robine S, Pinçon-Raymond M, Cardot P, Lacasa M, Ribeiro A. Hepatocyte nuclear factor 4alpha, a key factor for homeostasis, cell architecture, and barrier function of the adult intestinal epithelium. Mol Cell Biol 2009; 29: 6294-6308 [PMID: 19805521 DOI: 10.1128/MCB.00939-09].
59. Konev AY, Tribus M, Park SY, Podhraski V, Lim CY, Emelyanov AV, Vershilova E, Pirrotta V, Kadonaga JT, Lusser A, Fyodorov DV. CHD1 motor protein is required for deposition of histone variant H3.3 into chromatin in vivo. Science 2007; 317: 1087-1090 [PMID: 17717186 DOI: 10.1126/science.1145339]
60. Tai HH, Geisterfer M, Bell JC, Moniwa M, Davie JR, Boucher L, McBurney MW. CHD1 associates with NCoR and histone deacetylase as well as with RNA splicing proteins. Biochem Biophys Res Commun 2003; 308: 170-176 [PMID: 12890497 DOI: 10.1016/S0006-291X(03)01354-8]
61. Bramlage B, Kosciessa U, Doenecke D. Differential expression of the murine histone genes H3.3A and H3.3B. Differentiation 1997; 62: 13-20 [PMID: 9373943 DOI: 10.1046/j.1432-0436.1997. 6210013.x]
62. Ahmad K, Henikoff S. The histone variant H3.3 marks active chromatin by replication-independent nucleosome assembly. Mol Cell 2002; 9: 1191-1200 [PMID: 12086617 DOI: 10.1016/ S1097-2765(02)00542-7]
63. Orsi GA, Couble P, Loppin B. Epigenetic and replacement roles of histone variant H3.3 in reproduction and development. Int J Dev Biol 2009; 53: 231-243 [PMID: 19412883 DOI: 10.1387/ ijdb.082653go]
64. Ng RK, Gurdon JB. Epigenetic memory of an active gene state depends on histone H3.3 incorporation into chromatin in the absence of transcription. Nat Cell Biol 2008; 10: 102-109 [PMID: 18066050 DOI: 10.1038/ncb1674]
65. Jin C, Zang C, Wei G, Cui K, Peng W, Zhao K, Felsenfeld G. H3.3/ H2A.Z double variant-containing nucleosomes mark 'nucleosomefree regions' of active promoters and other regulatory regions. Nat Genet 2009; 41: 941-945 [PMID: 19633671 DOI: 10.1038/ng.409]
66. Ahmad K, Henikoff S. Histone H3 variants specify modes of chromatin assembly. Proc Natl Acad Sci USA 2002; 99 Suppl 4: 16477-16484 [PMID: 12177448 DOI: 10.1073/pnas.172403699]
67. Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y, Zhuang SM. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res 2009; 69: 1135-1142 [PMID: 19155302 DOI: 10.1158/0008-5472. CAN-08-2886]
68. Friedman JM, Liang G, Liu CC, Wolff EM, Tsai YC, Ye W, Zhou X, Jones PA. The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2. Cancer Res 2009; 69: 2623-2629 [PMID: 19258506 DOI: 10.1158/0008-5472.CAN-08-3114]
69. Varambally S, Cao Q, Mani RS, Shankar S, Wang X, Ateeq B, Laxman B, Cao X, Jing X, Ramnarayanan K, Brenner JC, Yu J, Kim JH, Han B, Tan P, Kumar-Sinha C, Lonigro RJ, Palanisamy N, Maher CA, Chinnaiyan AM. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 2008; 322: 1695-1699 [PMID: 19008416 DOI: 10.1126/ science.1165395]
70. Xu C, Liu S, Fu H, Li S, Tie Y, Zhu J, Xing R, Jin Y, Sun Z, Zheng X. MicroRNA-193b regulates proliferation, migration and invasion in human hepatocellular carcinoma cells. Eur J Cancer 2010; 46: 2828-2836 [PMID: 20655737 DOI: 10.1016/j.ejca.2010.06.127]
71. Ma K, He Y, Zhang H, Fei Q, Niu D, Wang D, Ding X, Xu H, Chen X, Zhu J. DNA methylation-regulated miR-193a-3p dictates resistance of hepatocellular carcinoma to 5-fluorouracil via repression of SRSF2 expression. J Biol Chem 2012; 287: 5639-5649 [PMID: 22117060 DOI: 10.1074/jbc.M111.291229]
72. Gebeshuber CA, Kornauth C, Dong L, Sierig R, Seibler J, Reiss M, Tauber S, Bilban M, Wang S, Kain R, Böhmig GA, Moeller MJ, Gröne HJ, Englert C, Martinez J, Kerjaschki D. Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1. Nat Med 2013; 19: 481-487 [PMID: 23502960 DOI: 10.1038/nm.3142]
73. Perugorria MJ, Castillo J, Latasa MU, Goñi S, Segura V, Sangro B, Prieto J, Avila MA, Berasain C. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy. Cancer Res 2009; 69: 1358-1367 [PMID: 19190340 DOI: 10.1158/0008-5472.CAN-08-2545]
74. Voigt P, Tee WW, Reinberg D. A double take on bivalent promoters. Genes Dev 2013; 27: 1318-1338 [PMID: 23788621 DOI: 10.1101/ gad.219626.113]
75. Kornfeld JW, Baitzel C, Könner AC, Nicholls HT, Vogt MC, Herrmanns K, Scheja L, Haumaitre C, Wolf AM, Knippschild U, Seibler J, Cereghini S, Heeren J, Stoffel M, Brüning JC. Obesityinduced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b. Nature 2013; 494: 111-115 [PMID: 23389544 DOI: 10.1038/nature11793]
76. Coffinier C, Gresh L, Fiette L, Tronche F, Schütz G, Babinet C, Pontoglio M, Yaniv M, Barra J. Bile system morphogenesis defects and liver dysfunction upon targeted deletion of HNF1beta. Development 2002; 129: 1829-1838 [PMID: 11934849]
77. Braun CJ, Zhang X, Savelyeva I, Wolff S, Moll UM, Schepeler T, Ørntoft TF, Andersen CL, Dobbelstein M. p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest. Cancer Res 2008; 68: 10094-10104 [PMID: 19074875 DOI: 10.1158/0008-5472.CAN-08-1569]
78. Fullerton MD. AMP-activated protein kinase and its multifaceted regulation of hepatic metabolism. Curr Opin Lipidol 2016; 27: 172-180 [PMID: 26906549 DOI: 10.1097/MOL.00000000000 00273]
79. Motoshima H, Goldstein BJ, Igata M, Araki E. AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer. J Physiol 2006; 574: 63-71 [PMID: 16613876 DOI: 10.1113/jphysiol.2006.108324]
80. Mott JL, Kobayashi S, Bronk SF, Gores GJ. mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 2007; 26: 6133-6140 [PMID: 17404574 DOI: 10.1038/sj.onc.1210436]
81. Park SY, Lee JH, Ha M, Nam JW, Kim VN. miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat Struct Mol Biol 2009; 16: 23-29 [PMID: 19079265 DOI: 10.1038/nsmb.1533].
82. Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, Liu S, Alder H, Costinean S, Fernandez-Cymering C, Volinia S, Guler G, Morrison CD, Chan KK, Marcucci G, Calin GA, Huebner K, Croce CM. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA 2007; 104: 15805-15810 [PMID: 17890317 DOI: 10.1073/pnas.0707628104]
83. Garzon R, Liu S, Fabbri M, Liu Z, Heaphy CE, Callegari E, Schwind S, Pang J, Yu J, Muthusamy N, Havelange V, Volinia S, Blum W, Rush LJ, Perrotti D, Andreeff M, Bloomfield CD, Byrd JC, Chan K, Wu LC, Croce CM, Marcucci G. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 2009; 113: 6411-6418 [PMID: 19211935 DOI: 10.1182/blood-2008-07-170589]
84. Takada S, Berezikov E, Choi YL, Yamashita Y, Mano H. Potential role of miR-29b in modulation of Dnmt3a and Dnmt3b expression in primordial germ cells of female mouse embryos. RNA 2009; 15: 1507-1514 [PMID: 19509302 DOI: 10.1261/rna.1418309]
85. Ugalde AP, Ramsay AJ, de la Rosa J, Varela I, Mariño G, Cadiñanos J, Lu J, Freije JM, López-Otín C. Aging and chronic DNA damage response activate a regulatory pathway involving miR-29 and p53. EMBO J 2011; 30: 2219-2232 [PMID: 21522133 DOI: 10.1038/emboj.2011.124]
86. Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005; 438: 685-689 [PMID: 16258535 DOI: 10.1038/nature04303]
87. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, Watts L, Booten SL, Graham M, McKay R, Subramaniam A, Propp S, Lollo BA, Freier S, Bennett CF, Bhanot S, Monia BP. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006; 3: 87-98 [PMID: 16459310 DOI: 10.1016/ j.cmet.2006.01.005]
88. Coulouarn C, Factor VM, Andersen JB, Durkin ME, Thorgeirsson SS. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 2009; 28: 3526-3536 [PMID: 19617899 DOI: 10.1038/onc.2009.211]
89. Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin M, Sabbioni S, Calin GA, Grazi GL, Croce CM, Tavolari S, Chieco P, Negrini M, Bolondi L. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res 2009; 69: 5761-5767 [PMID: 19584283 DOI: 10.1158/0008-5472.CAN-08-4797]
90. Tsai WC, Hsu PW, Lai TC, Chau GY, Lin CW, Chen CM, Lin CD, Liao YL, Wang JL, Chau YP, Hsu MT, Hsiao M, Huang HD, Tsou AP. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology 2009; 49: 1571-1582 [PMID: 19296470 DOI: 10.1002/hep.22806]
91. Li ZY, Xi Y, Zhu WN, Zeng C, Zhang ZQ, Guo ZC, Hao DL, Liu G, Feng L, Chen HZ, Chen F, Lv X, Liu DP, Liang CC. Positive regulation of hepatic miR-122 expression by HNF4α. J Hepatol 2011; 55: 602-611 [PMID: 21241755 DOI: 10.1016/ j.jhep.2010.12.023]
92. Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007; 317: 121-124 [PMID: 17615358 DOI: 10.1126/science.1140485]